Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4
A Ghose, L McCann, S Makker… - … in medical oncology, 2024 - journals.sagepub.com
Ovarian cancer (OC) is the most lethal gynaecologic malignancy, attributed to its insidious
growth, non-specific symptoms and late presentation. Unfortunately, current screening …
growth, non-specific symptoms and late presentation. Unfortunately, current screening …
Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker
AER Kartikasari, E Cassar, MAM Razqan… - Frontiers in …, 2022 - frontiersin.org
High Tumor Necrosis Factor Receptor 2 (TNFR2) expression is characteristic of diverse
malignant cells during tumorigenesis. The protein is also expressed by many …
malignant cells during tumorigenesis. The protein is also expressed by many …
Volatile organic compounds as potential biomarkers for noninvasive disease detection by nanosensors: A comprehensive review
Biomarkers are biological molecules associated with physiological changes of the body and
aids in the detecting the onset of disease in patients. There is an urgent need for self …
aids in the detecting the onset of disease in patients. There is an urgent need for self …
Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment
M Monavarian, AT Elhaw, PW Tang, Z Javed… - Seminars in cancer …, 2022 - Elsevier
The ascites ecosystem in ovarian cancer is inhabited by complex cell types and is bathed in
an environment rich in cytokines, chemokines, and growth factors that directly and indirectly …
an environment rich in cytokines, chemokines, and growth factors that directly and indirectly …
Recent insight about HE4 role in ovarian cancer oncogenesis
E Anastasi, A Farina, T Granato, F Colaiacovo… - International Journal of …, 2023 - mdpi.com
Currently, ovarian cancer (OC) is a target of intense biomarkers research because of its
frequent late diagnosis and poor prognosis. Serum determination of Human epididymis …
frequent late diagnosis and poor prognosis. Serum determination of Human epididymis …
Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: Critical role of inflammation
Recent evidence indicates that targeting IL-6 provides broad therapeutic approaches to
several diseases. In patients with cancer, autoimmune diseases, severe respiratory …
several diseases. In patients with cancer, autoimmune diseases, severe respiratory …
Diagnostic accuracy of interleukin-6 in multiple diseases: An umbrella review of meta-analyses
Z Han, J Li, X Yi, T Zhang, D Liao, J You, J Ai - Heliyon, 2024 - cell.com
Objective This review aims to conduct a comprehensive study of the diagnostic accuracy of
interleukin-6 (IL-6) for multiple diseases by utilizing existing systematic reviews and meta …
interleukin-6 (IL-6) for multiple diseases by utilizing existing systematic reviews and meta …
Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies
MY Han, EH Borazanci - Frontiers in Oncology, 2023 - frontiersin.org
Malignant ascites is the accumulation of fluid in the peritoneum as a result of advanced
cancer and often signifies the terminal phase of the disease. Management of malignant …
cancer and often signifies the terminal phase of the disease. Management of malignant …
A Multiple-Array SPRi Biosensor as a Tool for Detection of Gynecological–Oncological Diseases
B Szymanska, Z Lukaszewski… - Biosensors, 2023 - mdpi.com
Diagnostics based on the determination of biomarkers in body fluids will be more successful
when several biomarkers are determined. A multiple-array SPRi biosensor for the …
when several biomarkers are determined. A multiple-array SPRi biosensor for the …
The Role of Interleukin 6 (IL6), Cancer Antigen—125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian …
S Muhammad, RJ Azwan, RS Rita, R Susanti… - Plos one, 2023 - journals.plos.org
Introduction A study of tumor resectability in pre-operative patients with advanced epithelial
ovarian cancer is required to predict primary surgical benefits accurately. This study aims to …
ovarian cancer is required to predict primary surgical benefits accurately. This study aims to …